CPHI 2025: Ingredia’s dairy-derived innovations for mobility, sleep, and holistic wellness
04 Nov 2025 | Ingredia
At CPHI 2025 in Frankfurt, Germany, Joanna Moro, clinical trial specialist at Ingredia, highlighted the company’s latest dairy-based innovations. She presented scientific support for the company’s latest bioactive ingredient for joint comfort, Xelflex, in seniors and athletes. This milk protein hydrolysate can decrease markers of inflammation and edema. She also detailed how Lactium helps manage stress and improve sleep quality. Moreover, Moro explained how Ingredia’s solutions can be synergistically combined to target stress, metabolism, immunity, and mobility.


















